Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma.

导出 OA

翻译打印收藏纠错

作者： Weijie,Xue ^[1] ; Kang,Qiu ^[2] ; Bingzi,Dong ^[3] ; Dong,Guo ^[4] ; Junhua,Fu ^[2] ; Chengzhan,Zhu ^[5] ; Zhaojian,Niu ^[6]

作者单位： Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan. ^[1] Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, No.16 Jiangsu Road, Qingdao, 266003, China. ^[2] Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, 266003, China. ^[3] Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao, 266003, China. ^[4] Department of Operation Room, The Affiliated Hospital of Qingdao University, No.16 Jiangsu Road, Qingdao, 266003, China. ^[5] Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, 266003, China. zhuchengz@qduhospital.cn. ^[6] Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, No.16 Jiangsu Road, Qingdao, 266003, China. nzj532@126.com. ^[7]

关键词 Colon adenocarcinoma Disulfidptosis Prognostic Tumor microenvironment lncRNA

DOI 10.1186/s12935-023-03065-8

PMID 37759294

发布时间 2023-11-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交